Literature DB >> 15525510

A pathway of sequential arginine-serine-rich domain-splicing signal interactions during mammalian spliceosome assembly.

Haihong Shen1, Michael R Green.   

Abstract

Serine-arginine (SR) proteins are general splicing factors and can function through binding to exonic splicing enhancers (ESEs). SR proteins and several other mammalian splicing factors contain an arginine-serine-rich (RS) domain required to promote splicing. We have recently found that the ESE bound RS domain functions by contacting the branchpoint. Here, we perform RNA-protein crosslinking experiments to show that the branchpoint is sequentially contacted first in complex E by the RS domain of the essential splicing factor U2AF(65) and then in the prespliceosome by the ESE bound RS domain. Although the ESE bound RS domain can promote formation of the prespliceosome, at least one additional SR protein is required for complete spliceosome assembly. We show that the RS domain of this additional SR protein contacts the 5' splice site specifically in the mature spliceosome. We propose that direct contact with splicing signals is a general mechanism by which RS domains promote splicing.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15525510     DOI: 10.1016/j.molcel.2004.10.021

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  90 in total

1.  CEF1/CDC5 alleles modulate transitions between catalytic conformations of the spliceosome.

Authors:  Charles C Query; Maria M Konarska
Journal:  RNA       Date:  2012-03-08       Impact factor: 4.942

2.  Genomic mRNA profiling reveals compensatory mechanisms for the requirement of the essential splicing factor U2AF.

Authors:  Vinod Sridharan; Joseph Heimiller; Ravinder Singh
Journal:  Mol Cell Biol       Date:  2010-12-13       Impact factor: 4.272

Review 3.  The RNAissance family: SR proteins as multifaceted regulators of gene expression.

Authors:  Jonathan M Howard; Jeremy R Sanford
Journal:  Wiley Interdiscip Rev RNA       Date:  2014-08-22       Impact factor: 9.957

4.  Serine/arginine-rich protein-dependent suppression of exon skipping by exonic splicing enhancers.

Authors:  El Chérif Ibrahim; Thomas D Schaal; Klemens J Hertel; Robin Reed; Tom Maniatis
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-07       Impact factor: 11.205

5.  A simple answer for a splicing conundrum.

Authors:  Douglas L Black
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-28       Impact factor: 11.205

6.  Regulated cellular partitioning of SR protein-specific kinases in mammalian cells.

Authors:  Jian-Hua Ding; Xiang-Yang Zhong; Jonathan C Hagopian; Marissa M Cruz; Gourisankar Ghosh; James Feramisco; Joseph A Adams; Xiang-Dong Fu
Journal:  Mol Biol Cell       Date:  2005-11-30       Impact factor: 4.138

7.  Chironomus tentans-repressor splicing factor represses SR protein function locally on pre-mRNA exons and is displaced at correct splice sites.

Authors:  Petra Björk; Ingela Wetterberg-Strandh; Göran Baurén; Lars Wieslander
Journal:  Mol Biol Cell       Date:  2005-10-19       Impact factor: 4.138

8.  Phosphorylation by SR kinases regulates the binding of PTB-associated splicing factor (PSF) to the pre-mRNA polypyrimidine tract.

Authors:  Ching-Jung Huang; Zhaohua Tang; Ren-Jang Lin; Philip W Tucker
Journal:  FEBS Lett       Date:  2006-12-14       Impact factor: 4.124

9.  Selective modification of alternative splicing by indole derivatives that target serine-arginine-rich protein splicing factors.

Authors:  Johann Soret; Nadia Bakkour; Sophie Maire; Sébastien Durand; Latifa Zekri; Mathieu Gabut; Weronika Fic; Gilles Divita; Christian Rivalle; Daniel Dauzonne; Chi Hung Nguyen; Philippe Jeanteur; Jamal Tazi
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-06       Impact factor: 11.205

10.  RBP16 stimulates trypanosome RNA editing in vitro at an early step in the editing reaction.

Authors:  Melissa M Miller; Kari Halbig; Jorge Cruz-Reyes; Laurie K Read
Journal:  RNA       Date:  2006-05-11       Impact factor: 4.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.